RAC1 and malignant colon neoplasm: In agreement with our data, a previous report demonstrated that a dominant-negative Rac1 mutant drastically inhibits Wnt signaling in colon cancer followed by a decrease in its target gene transcription (Esufali and Bapat, 2004).